A detailed history of Kb Financial Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Kb Financial Partners, LLC holds 296 shares of VRTX stock, worth $138,252. This represents 0.03% of its overall portfolio holdings.

Number of Shares
296
Previous 309 4.21%
Holding current value
$138,252
Previous $109,000 5.5%
% of portfolio
0.03%
Previous 0.03%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$338.18 - $362.46 $4,396 - $4,711
-13 Reduced 4.21%
296 $103,000
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $349,635 - $391,323
-1,112 Reduced 78.25%
309 $109,000
Q1 2023

May 16, 2023

BUY
$283.23 - $323.1 $38,519 - $43,941
136 Added 10.58%
1,421 $448,000
Q4 2022

Feb 17, 2023

SELL
$285.76 - $321.48 $2,286 - $2,571
-8 Reduced 0.62%
1,285 $371,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $58,599 - $65,383
214 Added 19.83%
1,293 $374,000
Q2 2022

Aug 11, 2022

SELL
$234.96 - $292.55 $36,653 - $45,637
-156 Reduced 12.63%
1,079 $304,000
Q1 2022

May 17, 2022

BUY
$221.42 - $260.97 $21,699 - $25,575
98 Added 8.62%
1,235 $322,000
Q4 2021

Feb 18, 2022

BUY
$177.01 - $223.45 $201,260 - $254,062
1,137 New
1,137 $250,000
Q3 2021

Nov 16, 2021

SELL
$181.39 - $202.99 $2,358 - $2,638
-13 Closed
0 $0
Q1 2021

Jun 08, 2021

BUY
$207.02 - $241.31 $2,691 - $3,137
13 New
13 $3,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Kb Financial Partners, LLC Portfolio

Follow Kb Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kb Financial Partners, LLC with notifications on news.